- Home
- NPCE vs ZYXI Comparison
NPCE vs ZYXI Comparison
Compare NPCE & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCE
- ZYXI
- Stock Information
- Founded
- NPCE 1997
- ZYXI 1996
- Country
- NPCE United States
- ZYXI United States
- Employees
- NPCE N/A
- ZYXI N/A
- Industry
- NPCE Medical Specialities
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NPCE Health Care
- ZYXI Health Care
- Exchange
- NPCE Nasdaq
- ZYXI Nasdaq
- Market Cap
- NPCE 217.5M
- ZYXI 248.4M
- IPO Year
- NPCE 2021
- ZYXI N/A
- Fundamental
- Price
- NPCE $8.98
- ZYXI $7.80
- Analyst Decision
- NPCE Buy
- ZYXI Strong Buy
- Analyst Count
- NPCE 7
- ZYXI 2
- Target Price
- NPCE $15.71
- ZYXI $14.00
- AVG Volume (30 Days)
- NPCE 120.5K
- ZYXI 127.5K
- Earning Date
- NPCE 11-12-2024
- ZYXI 10-24-2024
- Dividend Yield
- NPCE N/A
- ZYXI N/A
- EPS Growth
- NPCE N/A
- ZYXI N/A
- EPS
- NPCE N/A
- ZYXI 0.15
- Revenue
- NPCE $76,452,000.00
- ZYXI $193,665,000.00
- Revenue This Year
- NPCE $20.21
- ZYXI $10.70
- Revenue Next Year
- NPCE $15.04
- ZYXI $19.78
- P/E Ratio
- NPCE N/A
- ZYXI $52.81
- Revenue Growth
- NPCE 27.00
- ZYXI 4.21
- 52 Week Low
- NPCE $5.45
- ZYXI $7.15
- 52 Week High
- NPCE $18.15
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- NPCE 66.14
- ZYXI 41.91
- Support Level
- NPCE $6.63
- ZYXI $8.68
- Resistance Level
- NPCE $10.42
- ZYXI $9.33
- Average True Range (ATR)
- NPCE 0.83
- ZYXI 0.43
- MACD
- NPCE 0.30
- ZYXI -0.12
- Stochastic Oscillator
- NPCE 67.20
- ZYXI 4.97
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.